LIVER FAILURE
Clinical trials for LIVER FAILURE explained in plain language.
Never miss a new study
Get alerted when new LIVER FAILURE trials appear
Sign up with your email to follow new studies for LIVER FAILURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a single cell treatment free liver transplant patients from daily anti-rejection pills?
Disease control OngoingThis study tests a new treatment called QEL-001, made from a patient's own cells, to help their body accept a donated liver without needing lifelong anti-rejection drugs. About 33 adults who received a liver transplant 1 to 5 years ago will receive the therapy and then try to sto…
Matched conditions: LIVER FAILURE
Phase: PHASE1, PHASE2 • Sponsor: Quell Therapeutics Limited • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for cancer patients with organ failure: early trial combines targeted drug with chemo
Disease control OngoingThis early-phase study tests a drug called veliparib combined with two standard chemotherapy drugs (carboplatin and paclitaxel) in people with advanced solid tumors who also have liver or kidney dysfunction. The main goals are to find the safest dose and understand how the body p…
Matched conditions: LIVER FAILURE
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
2000-Patient study aims to forecast liver failure prognosis
Knowledge-focused OngoingThis study looks back and forward at 2000 people with severe liver failure caused by hepatitis B. Researchers collect lab results and blood samples to create a tool that can better predict how patients will do and whether complications may arise. The goal is to improve care, not …
Matched conditions: LIVER FAILURE
Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Knowledge-focused
Last updated May 17, 2026 06:51 UTC